- Home
- RELX vs CAH Comparison
RELX vs CAH Comparison
Compare RELX & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RELX | CAH |
|---|---|---|
| Founded | 1903 | 1979 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.1B | 55.6B |
| IPO Year | 2007 | 1994 |
Fundamental Metrics
Financial Performance| Metric | RELX | CAH |
|---|---|---|
| Price | $34.04 | $233.14 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 17 |
| Target Price | $53.35 | ★ $270.33 |
| AVG Volume (30 Days) | ★ 1.9M | 1.5M |
| Earning Date | 07-23-2026 | 11-05-2026 |
| Dividend Yield | ★ 2.71% | 0.89% |
| EPS Growth | N/A | ★ 12.09 |
| EPS | N/A | ★ 7.23 |
| Revenue | N/A | ★ $254,248,000,000.00 |
| Revenue This Year | $4.98 | $4.57 |
| Revenue Next Year | $6.55 | $6.19 |
| P/E Ratio | ★ $20.27 | $32.15 |
| Revenue Growth | N/A | ★ 14.23 |
| 52 Week Low | $27.57 | $151.87 |
| 52 Week High | $47.22 | $258.30 |
Technical Indicators
Market Signals| Indicator | RELX | CAH |
|---|---|---|
| Relative Strength Index (RSI) | 49.55 | 55.06 |
| Support Level | $33.47 | $227.68 |
| Resistance Level | $34.19 | $243.21 |
| Average True Range (ATR) | 0.52 | 4.95 |
| MACD | 0.07 | 0.87 |
| Stochastic Oscillator | 71.69 | 84.29 |
Price Performance
Historical ComparisonAbout RELX RELX PLC PLC
RELX is a developer of information-based analytics and decision tools designed to support research, risk assessment, legal work, and business operations. The company offers data analytics, scientific and technical information resources, legal research tools, and event management platforms. This enables professionals, researchers, legal teams, and businesses to make informed decisions and improve operational efficiency.
About CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.